MEDICAL PROPERTIES TRUST INC (MPT) Fundamental Analysis & Valuation

NYSE:MPT • US58463J3041

Current stock price

4.655 USD
+0.03 (+0.54%)
Last:

This MPT fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. MPT Profitability Analysis

1.1 Basic Checks

  • MPT had negative earnings in the past year.
  • In the past year MPT had a positive cash flow from operations.
  • In multiple years MPT reported negative net income over the last 5 years.
  • In the past 5 years MPT always reported a positive cash flow from operatings.
MPT Yearly Net Income VS EBIT VS OCF VS FCFMPT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B -1B -2B -3B -4B

1.2 Ratios

  • MPT's Return On Assets of -1.85% is on the low side compared to the rest of the industry. MPT is outperformed by 69.67% of its industry peers.
  • The Return On Equity of MPT (-6.03%) is worse than 68.85% of its industry peers.
  • MPT has a Return On Invested Capital (2.98%) which is in line with its industry peers.
  • MPT had an Average Return On Invested Capital over the past 3 years of 1.86%. This is in line with the industry average of 3.11%.
  • The 3 year average ROIC (1.86%) for MPT is below the current ROIC(2.98%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -1.85%
ROE -6.03%
ROIC 2.98%
ROA(3y)-7.26%
ROA(5y)-2.8%
ROE(3y)-21.08%
ROE(5y)-9%
ROIC(3y)1.86%
ROIC(5y)2.78%
MPT Yearly ROA, ROE, ROICMPT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 -40

1.3 Margins

  • With an excellent Operating Margin value of 55.53%, MPT belongs to the best of the industry, outperforming 96.72% of the companies in the same industry.
  • MPT's Operating Margin has declined in the last couple of years.
  • MPT has a Gross Margin of 96.25%. This is amongst the best in the industry. MPT outperforms 96.72% of its industry peers.
  • MPT's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 55.53%
PM (TTM) N/A
GM 96.25%
OM growth 3Y-5.14%
OM growth 5Y-3.49%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.25%
GM growth 5Y-0.37%
MPT Yearly Profit, Operating, Gross MarginsMPT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100 -100 -200

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. MPT Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), MPT is destroying value.
  • MPT has less shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, MPT has more shares outstanding
  • The debt/assets ratio for MPT is higher compared to a year ago.
MPT Yearly Shares OutstandingMPT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M
MPT Yearly Total Debt VS Total AssetsMPT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B

2.2 Solvency

  • Based on the Altman-Z score of 0.02, we must say that MPT is in the distress zone and has some risk of bankruptcy.
  • The Altman-Z score of MPT (0.02) is worse than 72.13% of its industry peers.
  • The Debt to FCF ratio of MPT is 1117.91, which is on the high side as it means it would take MPT, 1117.91 years of fcf income to pay off all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 1117.91, MPT is in line with its industry, outperforming 58.20% of the companies in the same industry.
  • A Debt/Equity ratio of 2.11 is on the high side and indicates that MPT has dependencies on debt financing.
  • The Debt to Equity ratio of MPT (2.11) is worse than 68.85% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.11
Debt/FCF 1117.91
Altman-Z 0.02
ROIC/WACC0.47
WACC6.31%
MPT Yearly LT Debt VS Equity VS FCFMPT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5B 10B

2.3 Liquidity

  • MPT has a Current Ratio of 2.10. This indicates that MPT is financially healthy and has no problem in meeting its short term obligations.
  • MPT has a better Current ratio (2.10) than 88.52% of its industry peers.
  • MPT has a Quick Ratio of 2.10. This indicates that MPT is financially healthy and has no problem in meeting its short term obligations.
  • MPT has a Quick ratio of 2.10. This is amongst the best in the industry. MPT outperforms 88.52% of its industry peers.
Industry RankSector Rank
Current Ratio 2.1
Quick Ratio 2.1
MPT Yearly Current Assets VS Current LiabilitesMPT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. MPT Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 89.39% over the past year.
  • MPT shows a decrease in Revenue. In the last year, the revenue decreased by -2.36%.
  • MPT shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -4.89% yearly.
EPS 1Y (TTM)89.39%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%104.35%
Revenue 1Y (TTM)-2.36%
Revenue growth 3Y-14.27%
Revenue growth 5Y-4.89%
Sales Q2Q%16.61%

3.2 Future

  • Based on estimates for the next years, MPT will show a very strong growth in Earnings Per Share. The EPS will grow by 60.25% on average per year.
  • MPT is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.56% yearly.
EPS Next Y133.19%
EPS Next 2Y60.25%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year7.32%
Revenue Next 2Y6.03%
Revenue Next 3Y3.88%
Revenue Next 5Y3.56%

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
MPT Yearly Revenue VS EstimatesMPT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B
MPT Yearly EPS VS EstimatesMPT Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 -2

More info and screens

Find the best growth stocksShow best growing peers

3

4. MPT Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for MPT. In the last year negative earnings were reported.
  • The Price/Forward Earnings ratio is 50.10, which means the current valuation is very expensive for MPT.
  • Based on the Price/Forward Earnings ratio, MPT is valued a bit cheaper than 61.48% of the companies in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 22.81. MPT is valued rather expensively when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 50.1
MPT Price Earnings VS Forward Price EarningsMPT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

  • MPT's Enterprise Value to EBITDA is on the same level as the industry average.
  • MPT's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 320.72
EV/EBITDA 14.67
MPT Per share dataMPT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as MPT's earnings are expected to grow with 60.25% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y60.25%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

4

5. MPT Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 7.71%, MPT is a good candidate for dividend investing.
  • MPT's Dividend Yield is a higher than the industry average which is at 7.54.
  • MPT's Dividend Yield is rather good when compared to the S&P500 average which is at 1.89.
Industry RankSector Rank
Dividend Yield 7.71%

5.2 History

  • The dividend of MPT decreases each year by -21.35%.
  • MPT has been paying a dividend for over 5 years, so it has already some track record.
Dividend Growth(5Y)-21.35%
Div Incr YearsN/A
Div Non Decr YearsN/A
MPT Yearly Dividends per shareMPT Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 2025 2026 0.2 0.4 0.6 0.8 1

5.3 Sustainability

  • The earnings of MPT are negative and hence is the payout ratio. MPT will probably not be able to sustain this dividend level.
DP-69.53%
EPS Next 2Y60.25%
EPS Next 3YN/A
MPT Yearly Income VS Free CF VS DividendMPT Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B -1B -2B -3B -4B

More info and screens

Find the best dividend stocksShow peers with best dividend

MPT Fundamentals: All Metrics, Ratios and Statistics

MEDICAL PROPERTIES TRUST INC

NYSE:MPT (4/1/2026, 3:31:06 PM)

4.655

+0.03 (+0.54%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)02-19
Earnings (Next)04-23
Inst Owners59.68%
Inst Owner ChangeN/A
Ins Owners17.76%
Ins Owner Change18.42%
Market Cap2.78B
Revenue(TTM)972.02M
Net Income(TTM)-277.94M
Analysts53.75
Price Target5.97 (28.25%)
Short Float %28.96%
Short Ratio18.39
Dividend
Industry RankSector Rank
Dividend Yield 7.71%
Yearly Dividend0.32
Dividend Growth(5Y)-21.35%
DP-69.53%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-Date03-12
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-834.32%
Min EPS beat(2)-1816.17%
Max EPS beat(2)147.53%
EPS beat(4)2
Avg EPS beat(4)-3339.11%
Min EPS beat(4)-11757.5%
Max EPS beat(4)147.53%
EPS beat(8)2
Avg EPS beat(8)-2222.45%
EPS beat(12)3
Avg EPS beat(12)-1454.49%
EPS beat(16)6
Avg EPS beat(16)-1085.69%
Revenue beat(2)2
Avg Revenue beat(2)5.9%
Min Revenue beat(2)0.7%
Max Revenue beat(2)11.11%
Revenue beat(4)3
Avg Revenue beat(4)2.59%
Min Revenue beat(4)-3.58%
Max Revenue beat(4)11.11%
Revenue beat(8)5
Avg Revenue beat(8)1.17%
Revenue beat(12)5
Avg Revenue beat(12)-12.03%
Revenue beat(16)6
Avg Revenue beat(16)-9.77%
PT rev (1m)2.5%
PT rev (3m)N/A
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)-12.38%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)0.67%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.2%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 50.1
P/S 2.86
P/FCF 320.72
P/OCF 12.06
P/B 0.6
P/tB 0.6
EV/EBITDA 14.67
EPS(TTM)-0.28
EYN/A
EPS(NY)0.09
Fwd EY2%
FCF(TTM)0.01
FCFY0.31%
OCF(TTM)0.39
OCFY8.29%
SpS1.63
BVpS7.71
TBVpS7.71
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -1.85%
ROE -6.03%
ROCE 3.77%
ROIC 2.98%
ROICexc 3.09%
ROICexgc 3.22%
OM 55.53%
PM (TTM) N/A
GM 96.25%
FCFM 0.89%
ROA(3y)-7.26%
ROA(5y)-2.8%
ROE(3y)-21.08%
ROE(5y)-9%
ROIC(3y)1.86%
ROIC(5y)2.78%
ROICexc(3y)1.91%
ROICexc(5y)2.85%
ROICexgc(3y)1.98%
ROICexgc(5y)2.93%
ROCE(3y)2.35%
ROCE(5y)3.52%
ROICexgc growth 3Y-9.84%
ROICexgc growth 5Y-5.4%
ROICexc growth 3Y-10.05%
ROICexc growth 5Y-5.8%
OM growth 3Y-5.14%
OM growth 5Y-3.49%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.25%
GM growth 5Y-0.37%
F-Score5
Asset Turnover0.06
Health
Industry RankSector Rank
Debt/Equity 2.11
Debt/FCF 1117.91
Debt/EBITDA 11.93
Cap/Depr 81.41%
Cap/Sales 22.85%
Interest Coverage 1.18
Cash Conversion 28.4%
Profit Quality N/A
Current Ratio 2.1
Quick Ratio 2.1
Altman-Z 0.02
F-Score5
WACC6.31%
ROIC/WACC0.47
Cap/Depr(3y)59.67%
Cap/Depr(5y)443.89%
Cap/Sales(3y)27.19%
Cap/Sales(5y)105.16%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)89.39%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%104.35%
EPS Next Y133.19%
EPS Next 2Y60.25%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-2.36%
Revenue growth 3Y-14.27%
Revenue growth 5Y-4.89%
Sales Q2Q%16.61%
Revenue Next Year7.32%
Revenue Next 2Y6.03%
Revenue Next 3Y3.88%
Revenue Next 5Y3.56%
EBIT growth 1Y39.53%
EBIT growth 3Y-18.68%
EBIT growth 5Y-8.21%
EBIT Next Year71.19%
EBIT Next 3Y20.45%
EBIT Next 5Y13.18%
FCF growth 1Y-85.56%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-5.99%
OCF growth 3Y-32.16%
OCF growth 5Y-17.87%

MEDICAL PROPERTIES TRUST INC / MPT Fundamental Analysis FAQ

What is the ChartMill fundamental rating of MEDICAL PROPERTIES TRUST INC (MPT) stock?

ChartMill assigns a fundamental rating of 4 / 10 to MPT.


What is the valuation status of MEDICAL PROPERTIES TRUST INC (MPT) stock?

ChartMill assigns a valuation rating of 3 / 10 to MEDICAL PROPERTIES TRUST INC (MPT). This can be considered as Overvalued.


What is the profitability of MPT stock?

MEDICAL PROPERTIES TRUST INC (MPT) has a profitability rating of 4 / 10.


What is the financial health of MEDICAL PROPERTIES TRUST INC (MPT) stock?

The financial health rating of MEDICAL PROPERTIES TRUST INC (MPT) is 4 / 10.


What is the earnings growth outlook for MEDICAL PROPERTIES TRUST INC?

The Earnings per Share (EPS) of MEDICAL PROPERTIES TRUST INC (MPT) is expected to grow by 133.19% in the next year.